tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy
PremiumRatingsTempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy
1M ago
Tempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Tempest Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
1M ago
Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting
Premium
Company Announcements
Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting
2M ago
Tempest Therapeutics Announces New Leadership and Acquisition
PremiumCompany AnnouncementsTempest Therapeutics Announces New Leadership and Acquisition
4M ago
Tempest Therpeutics trading halted, volatility trading pause
Premium
The Fly
Tempest Therpeutics trading halted, volatility trading pause
4M ago
Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience
Premium
The Fly
Tempest announces acquisition of new dual-CAR T programs from Factor Bioscience
4M ago
Tempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
PremiumCompany AnnouncementsTempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
4M ago
Six new option listings and  option delistings on October 20th
Premium
The Fly
Six new option listings and option delistings on October 20th
5M ago
Tempest Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Tempest Therapeutics Reports Q2 2025 Financial Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100